Express Scripts (ESRX) 72.22 $ESRX
Express Scripts Holding Company to Present at an Upcoming Conference
PR Newswire - 2 hrs 29 mins ago
Express Scripts Holding Company (Nasdaq: ESRX) (the "Company" or "Express Scripts"
announced today that it will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 14, 2016 at 1:00 p.m. Eastern Time (12:00 p.m. Central Time).
ESRX: 72.22 (-0.48)
Express Scripts' New Program to Lower Diabetes Care Costs
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 9:00AM CDT
Express Scripts Holding Company (ESRX) has launched the Diabetes Care Value Program to lower costs for patients and provide better care.
ESRX: 72.22 (-0.48), ANIP: 61.42 (+1.68), LLY: 77.23 (-0.52)
Express Scripts Launches Diabetes Care Value Programâ", Guaranteeing More Affordable, Higher-Quality Diabetes Care
PR Newswire - Tue Aug 30, 11:01PM CDT
Express Scripts (NASDAQ: ESRX) today announced the launch of its Diabetes Care Value Programâ", the industry's most comprehensive approach to improve pharmacy care while controlling plan costs for people with diabetes.
ESRX: 72.22 (-0.48)
Blog Coverage Walgreens Boots Alliance Partners with Prime Therapeutics for a Bigger Slice of the Prescription Drug Market
ACCESSWIRE - Tue Aug 30, 8:15AM CDT
LONDON, UK / ACCESSWIRE / August 30, 2016 / Active Wall St. blog coverage looks at the headline from Walgreens Boots Alliance, Inc. (NASDAQ: WBA) announced a strategic partnership with pharmacy benefit manager (PBM) Prime Therapeutics on August 29, 2016 to form a new retail pharmacy network that combines mail order and speciality pharma business. Register with us now for your free membership and blog access at: http://www.activewallst.com/register/.
ESRX: 72.22 (-0.48), WBA: 81.54 (+0.83), UNH: 135.74 (-0.31), RAD: 7.54 (+0.01)
Mylan launching cheaper, generic version of EpiPen
By LINDA A. JOHNSON and TOM MURPHY - AP - Mon Aug 29, 4:20PM CDT
The maker of EpiPens will start selling a cheaper, generic version of the emergency allergy shots as the furor over repeated U.S. price hikes continues — and looming competition threatens its near-monopoly.
ESRX: 72.22 (-0.48), MYL: 41.92 (-0.44)
Stock Market News for August 26, 2016
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 9:09AM CDT
Benchmarks finished in the red on Thursday as investors refrained from making big bets ahead of Fed Chief Janet Yellen’s speech at Jackson Hole, Wyoming today
MNK: 75.59 (+1.05), TSLA: 200.77 (-11.24), ENDP: 20.23 (-0.47), F: 12.44 (-0.16), MDT: 86.98 (-0.05), GME: 28.03 (-0.36), MYL: 41.92 (-0.44), PDCO: 46.03 (+0.03), TIF: 70.37 (-1.00), BA: 129.90 (+0.45), ESRX: 72.22 (-0.48), STJ: 78.14 (+0.22), SSYS: 21.33 (-0.01), TECD: 73.34 (-0.90), ADSK: 67.37 (-0.03)
Mylan boosts EpiPen patient programs, doesn't budge on price
By LINDA A. JOHNSON and TOM MURPHY - AP - Thu Aug 25, 4:45PM CDT
The maker of EpiPens offered patients more help to pay for its costly emergency allergy shots but didn't budge Thursday on the $608 price.
ESRX: 72.22 (-0.48), VRX: 29.12 (+0.09), MYL: 41.92 (-0.44), VRX.TO: 38.09 (unch)
Look for Shares of Express Scripts to Potentially Rebound after Yesterday's 4.00% Sell Off
Comtex SmarTrend(R) - Thu Aug 25, 11:59AM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $73.01 to a high of $76.08. Yesterday, the shares fell 4.0%, which took the trading range below the 3-day low of $76.00 on volume of 5.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ESRX: 72.22 (-0.48)
SmarTrend Watching for Potential Rebound in Shares of Express Scripts After 4.00% Loss
Comtex SmarTrend(R) - Thu Aug 25, 11:57AM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $73.01 to a high of $76.08. Yesterday, the shares fell 4.0%, which took the trading range below the 3-day low of $76.00 on volume of 5.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ESRX: 72.22 (-0.48)
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Express Scripts Holding Company for Potential Breaches Of Fiduciary Duty By Its Board of Directors
PR Newswire - Thu Aug 25, 11:51AM CDT
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Express Scripts Holding Company (NASDAQ: ESRX).
ANTM: 123.36 (-1.72), ESRX: 72.22 (-0.48)
PharmCo to Offer Emergency Prescriptions to Residents in Louisiana Flood Zone
Marketwired - Thu Aug 25, 9:10AM CDT
MIAMI, FL--(Marketwired - August 25, 2016) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, has begun offering emergency prescription services to Louisiana Flood Zone residents.
ESRX: 72.22 (-0.48)
Express Scripts (ESRX) Breaks Through Support at $76.38
Comtex SmarTrend(R) - Fri Aug 19, 8:39AM CDT
Shares of Express Scripts (NASDAQ:ESRX) opened today below their pivot of $76.77 and have already reached the first level of support at $76.38. Should the shares continue to fall, the support pivots of $76.15 and $75.53 will be of interest.
ESRX: 72.22 (-0.48)
Watch for Express Scripts to Potentially Pullback After Gaining 1.20% Yesterday
Comtex SmarTrend(R) - Mon Aug 15, 2:48PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $76.25 to a high of $77.14. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $76.65 on volume of 875,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 72.22 (-0.48)
Express Scripts Set to Possibly Pullback After Yesterday's Rally of 1.08%
Comtex SmarTrend(R) - Fri Aug 05, 1:48PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $75.73 to a high of $76.75. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $76.41 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 72.22 (-0.48)
Express Scripts Announces Final Results of Maximum Tender Offers
PR Newswire - Thu Jul 28, 8:15AM CDT
Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts" today announced the final tender results for its previously announced tender offers (the "Maximum Tender Offers" to purchase for cash up to an aggregate principal amount of the debt securities listed in the table below (collectively, the "Notes" and each a "series" that will not result in an aggregate amount that all holders of any such series of Notes are entitled to receive, excluding accrued and unpaid interest, for their Notes of such series that are validly tendered and accepted for purchase in the Maximum Tender Offers exceeding the applicable Aggregate Maximum Tender Amount set forth in the table below. The Maximum Tender Offers were made pursuant to the terms and conditions set forth in the offer to purchase, dated June 29, 2016, as amended by the Company's press releases dated July 14, 2016 announcing the pricing and the early tender results of the Maximum Tender Offers, and the related letter of transmittal (as they may each be amended or supplemented from time to time, the "Tender Offer Documents" . The Company refers investors to the Tender Offer Documents for the complete terms and conditions of the Maximum Tender Offers.
ESRX: 72.22 (-0.48)
Top 7 Research Reports for July 27, 2016
Sheraz Mian - Zacks Investment Research - Wed Jul 27, 1:01PM CDT
Top 7 Research Reports for July 27, 2016
RAI: 49.75 (+0.18), SWK: 123.57 (-0.18), ESRX: 72.22 (-0.48), HON: 116.13 (-0.58), CHK: 6.25 (-0.10), TXN: 69.70 (+0.16), VFC: 61.56 (-0.49)
Express Scripts (ESRX) Posts In-Line Earnings, Lags Revenues (Revised)
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 10:19AM CDT
Pharmacy benefit manager Express Scripts Holding Company (ESRX) posted second-quarter 2016 earnings per share (excluding special items) of $1.57, in line with the Zacks Consensus Estimate.
ANTM: 123.36 (-1.72), JNJ: 119.08 (-0.26), ESRX: 72.22 (-0.48), GILD: 77.42 (-0.96)
DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit Against Express Scripts Holding Company and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Jun 23, 10:41PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 23, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company" (NASDAQ: ESRX) concerning possible violations of federal securities laws between February 24, 2015 and March 21, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 5, 2016, lead plaintiff motion deadline.
ESRX: 72.22 (-0.48)
Express Scripts Holding Company to Present at an Upcoming Conference
PR Newswire - 2 hrs 29 mins ago
Express Scripts Holding Company (Nasdaq: ESRX) (the "Company" or "Express Scripts"
announced today that it will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 14, 2016 at 1:00 p.m. Eastern Time (12:00 p.m. Central Time). ESRX: 72.22 (-0.48)
Express Scripts' New Program to Lower Diabetes Care Costs
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 9:00AM CDT
Express Scripts Holding Company (ESRX) has launched the Diabetes Care Value Program to lower costs for patients and provide better care.
ESRX: 72.22 (-0.48), ANIP: 61.42 (+1.68), LLY: 77.23 (-0.52)
Express Scripts Launches Diabetes Care Value Programâ", Guaranteeing More Affordable, Higher-Quality Diabetes Care
PR Newswire - Tue Aug 30, 11:01PM CDT
Express Scripts (NASDAQ: ESRX) today announced the launch of its Diabetes Care Value Programâ", the industry's most comprehensive approach to improve pharmacy care while controlling plan costs for people with diabetes.
ESRX: 72.22 (-0.48)
Blog Coverage Walgreens Boots Alliance Partners with Prime Therapeutics for a Bigger Slice of the Prescription Drug Market
ACCESSWIRE - Tue Aug 30, 8:15AM CDT
LONDON, UK / ACCESSWIRE / August 30, 2016 / Active Wall St. blog coverage looks at the headline from Walgreens Boots Alliance, Inc. (NASDAQ: WBA) announced a strategic partnership with pharmacy benefit manager (PBM) Prime Therapeutics on August 29, 2016 to form a new retail pharmacy network that combines mail order and speciality pharma business. Register with us now for your free membership and blog access at: http://www.activewallst.com/register/.
ESRX: 72.22 (-0.48), WBA: 81.54 (+0.83), UNH: 135.74 (-0.31), RAD: 7.54 (+0.01)
Mylan launching cheaper, generic version of EpiPen
By LINDA A. JOHNSON and TOM MURPHY - AP - Mon Aug 29, 4:20PM CDT
The maker of EpiPens will start selling a cheaper, generic version of the emergency allergy shots as the furor over repeated U.S. price hikes continues — and looming competition threatens its near-monopoly.
ESRX: 72.22 (-0.48), MYL: 41.92 (-0.44)
Stock Market News for August 26, 2016
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 9:09AM CDT
Benchmarks finished in the red on Thursday as investors refrained from making big bets ahead of Fed Chief Janet Yellen’s speech at Jackson Hole, Wyoming today
MNK: 75.59 (+1.05), TSLA: 200.77 (-11.24), ENDP: 20.23 (-0.47), F: 12.44 (-0.16), MDT: 86.98 (-0.05), GME: 28.03 (-0.36), MYL: 41.92 (-0.44), PDCO: 46.03 (+0.03), TIF: 70.37 (-1.00), BA: 129.90 (+0.45), ESRX: 72.22 (-0.48), STJ: 78.14 (+0.22), SSYS: 21.33 (-0.01), TECD: 73.34 (-0.90), ADSK: 67.37 (-0.03)
Mylan boosts EpiPen patient programs, doesn't budge on price
By LINDA A. JOHNSON and TOM MURPHY - AP - Thu Aug 25, 4:45PM CDT
The maker of EpiPens offered patients more help to pay for its costly emergency allergy shots but didn't budge Thursday on the $608 price.
ESRX: 72.22 (-0.48), VRX: 29.12 (+0.09), MYL: 41.92 (-0.44), VRX.TO: 38.09 (unch)
Look for Shares of Express Scripts to Potentially Rebound after Yesterday's 4.00% Sell Off
Comtex SmarTrend(R) - Thu Aug 25, 11:59AM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $73.01 to a high of $76.08. Yesterday, the shares fell 4.0%, which took the trading range below the 3-day low of $76.00 on volume of 5.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ESRX: 72.22 (-0.48)
SmarTrend Watching for Potential Rebound in Shares of Express Scripts After 4.00% Loss
Comtex SmarTrend(R) - Thu Aug 25, 11:57AM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $73.01 to a high of $76.08. Yesterday, the shares fell 4.0%, which took the trading range below the 3-day low of $76.00 on volume of 5.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ESRX: 72.22 (-0.48)
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Express Scripts Holding Company for Potential Breaches Of Fiduciary Duty By Its Board of Directors
PR Newswire - Thu Aug 25, 11:51AM CDT
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Express Scripts Holding Company (NASDAQ: ESRX).
ANTM: 123.36 (-1.72), ESRX: 72.22 (-0.48)
PharmCo to Offer Emergency Prescriptions to Residents in Louisiana Flood Zone
Marketwired - Thu Aug 25, 9:10AM CDT
MIAMI, FL--(Marketwired - August 25, 2016) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, has begun offering emergency prescription services to Louisiana Flood Zone residents.
ESRX: 72.22 (-0.48)
Express Scripts (ESRX) Breaks Through Support at $76.38
Comtex SmarTrend(R) - Fri Aug 19, 8:39AM CDT
Shares of Express Scripts (NASDAQ:ESRX) opened today below their pivot of $76.77 and have already reached the first level of support at $76.38. Should the shares continue to fall, the support pivots of $76.15 and $75.53 will be of interest.
ESRX: 72.22 (-0.48)
Watch for Express Scripts to Potentially Pullback After Gaining 1.20% Yesterday
Comtex SmarTrend(R) - Mon Aug 15, 2:48PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $76.25 to a high of $77.14. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $76.65 on volume of 875,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 72.22 (-0.48)
Express Scripts Set to Possibly Pullback After Yesterday's Rally of 1.08%
Comtex SmarTrend(R) - Fri Aug 05, 1:48PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $75.73 to a high of $76.75. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $76.41 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 72.22 (-0.48)
Express Scripts Announces Final Results of Maximum Tender Offers
PR Newswire - Thu Jul 28, 8:15AM CDT
Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts"
today announced the final tender results for its previously announced tender offers (the "Maximum Tender Offers" to purchase for cash up to an aggregate principal amount of the debt securities listed in the table below (collectively, the "Notes" and each a "series" that will not result in an aggregate amount that all holders of any such series of Notes are entitled to receive, excluding accrued and unpaid interest, for their Notes of such series that are validly tendered and accepted for purchase in the Maximum Tender Offers exceeding the applicable Aggregate Maximum Tender Amount set forth in the table below. The Maximum Tender Offers were made pursuant to the terms and conditions set forth in the offer to purchase, dated June 29, 2016, as amended by the Company's press releases dated July 14, 2016 announcing the pricing and the early tender results of the Maximum Tender Offers, and the related letter of transmittal (as they may each be amended or supplemented from time to time, the "Tender Offer Documents" . The Company refers investors to the Tender Offer Documents for the complete terms and conditions of the Maximum Tender Offers. ESRX: 72.22 (-0.48)
Top 7 Research Reports for July 27, 2016
Sheraz Mian - Zacks Investment Research - Wed Jul 27, 1:01PM CDT
Top 7 Research Reports for July 27, 2016
RAI: 49.75 (+0.18), SWK: 123.57 (-0.18), ESRX: 72.22 (-0.48), HON: 116.13 (-0.58), CHK: 6.25 (-0.10), TXN: 69.70 (+0.16), VFC: 61.56 (-0.49)
Express Scripts (ESRX) Posts In-Line Earnings, Lags Revenues (Revised)
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 10:19AM CDT
Pharmacy benefit manager Express Scripts Holding Company (ESRX) posted second-quarter 2016 earnings per share (excluding special items) of $1.57, in line with the Zacks Consensus Estimate.
ANTM: 123.36 (-1.72), JNJ: 119.08 (-0.26), ESRX: 72.22 (-0.48), GILD: 77.42 (-0.96)
DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit Against Express Scripts Holding Company and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Jun 23, 10:41PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 23, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company"
(NASDAQ: ESRX) concerning possible violations of federal securities laws between February 24, 2015 and March 21, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 5, 2016, lead plaintiff motion deadline. ESRX: 72.22 (-0.48)
